Inventures Investment Partners is an impact investment firm founded in 2011 and based in Brussels, Belgium. It focuses on social and environmental outcomes by backing early-stage European SMEs that address health, education, environment, economic growth and social progress, and align with the United Nations Sustainable Development Goals.

Established in 2015, The CoFoundry is a venture capital firm based in Antwerp, Belgium. It focuses on financing seed-stage startups and scale-ups through its CoFoundry fund.

Founded in 2009, Nausicaa Ventures is a Belgium-based venture capital firm specializing in early-stage and growth investments. It focuses on companies completing Series C or D financing rounds across various sectors such as healthcare technologies, ICT, manufacturing, clean tech, biotech, and industrial processes within a radius of 300 km from Brussels. The firm typically invests between €1 million to €4 million per company, with an average holding period of five years.

Capricorn Partners is an independent venture capital firm based in Leuven, Belgium. Founded in 1993, it manages venture capital funds and makes technology-driven investments in innovative European growth companies, emphasizing technology as a competitive advantage across sectors such as consumer, healthcare, information technology, software as a service, manufacturing, life sciences, oncology, big data, clean technology and digital health.

Gimv is a European investment company focused on private equity and venture capital. Founded in 1980 and headquartered in Antwerp, Belgium, it operates across Belgium, France, Germany, the Netherlands, and Switzerland. Gimv targets investments in a diversified range of sectors, including business-to-business services, financial services, healthcare, information technology, telecommunications, manufacturing, life sciences, and other technology-enabled sectors, with a focus on European opportunities. The firm emphasizes building long-term equity partnerships to support growth and value creation in portfolio companies.

Participatiemaatschappij Vlaanderen, established in 1995 and based in Brussels, Belgium, is a government organization focused on investing in startup and growth-stage companies. The organization targets diverse sectors including media, software, retail, infrastructure, energy, and real estate. Its investment portfolio is structured with a significant allocation towards financial fixed assets and receivables, reflecting its commitment to supporting emerging businesses. Participatiemaatschappij Vlaanderen plays a crucial role in fostering innovation and entrepreneurship in Belgium by providing essential financial backing to projects at various stages of development.

Founded in 2014, Volta Ventures is a venture capital firm based in Ghent and Amsterdam. It focuses on seed and early-stage investments in internet and software companies across the Benelux region. The firm actively supports founders by providing market insights, hiring assistance, strategic guidance, and follow-on financing.

Founded in 2015, V-Bio Ventures is a Belgium-based venture capital firm focused on investing in innovative life science companies across Europe. The firm concentrates on start-ups and early-stage companies with high growth potential, particularly those developing transformative technologies in biotech, pharmaceuticals, and sustainable agriculture.

Noshaq is a venture capital firm based in Liège, Belgium, founded in 1985. It provides seed, startup and growth capital to small and medium-sized companies, with a focus on the Liège region. The portfolio covers sectors such as energy, sustainable development, biotech, digital, Industry 4.0, real estate, quality food, cultural and creative industries, life sciences, agriculture and food, and reconversion. Noshaq typically takes a minority stake and may secure a seat on the board. In addition to equity investments, the firm offers convertible bonds, financing solutions, loans and support for strategic projects.

Société Régionale d'Investissement de Wallonie (SRIW) is a Belgian investment company established in 1979, headquartered in Liège. It specializes in private equity and venture capital, focusing on startups, growth, and turnaround investments. SRIW invests in a broad range of sectors, with a particular emphasis on real estate, metal engineering, and environmental technologies, among others. It primarily targets companies based in Wallonia, investing at least €1 million per portfolio company. SRIW takes majority or minority stakes and seeks board seats, often co-investing with other venture capitalists. It provides equity capital and various loan structures, including subordinated and secured loans. SRIW does not invest in steelmaking or the catering industry.

White Fund is a venture capital firm based in Liège, Belgium, established in 2019, that specializes in early-stage investments in the medical device and medtech sectors. The firm focuses on companies that have demonstrated a proof of concept for their technology and have shown objective market traction. White Fund primarily targets investments within Belgium but may consider opportunities in neighboring regions. It typically invests between €2 million and €3 million in each project, spanning two to three rounds of financing, with an exit strategy aimed at five to seven years. The firm is dedicated to supporting the pre-marketing stages and the launch of sales for innovative healthcare solutions, including prevention, diagnostic, monitoring, and treatment technologies.

Established in 2017, Imec.xpand is a Belgium-based venture capital firm focused on investing in early-stage innovations within the domains of deep tech, health, and agtech. The company aims to foster nanoelectronics-based innovation globally.

The Faktory is an accelerator, incubator and early-stage venture capital firm that supports IoT and connected-device startups with a business-to-business focus. Based in Angleur, Belgium, it operates across Belgium, France, Luxembourg and the Netherlands, making minority investments of roughly €0.2 million to €1 million per transaction (around 30% ownership) and providing mentoring and hands-on support to help startups validate markets, develop products and scale internationally.

Newion is a venture capital firm focused on early-stage investments in B2B software companies across Benelux, Nordics, and Germany. Founded in 2000, the company aims to support entrepreneurs in building category-leading software businesses that generate sustainable impact and excellent returns for investors.

Newton Biocapital is a Belgium-based venture capital fund focused on financing biotech and life science projects in Europe (Belgium, Netherlands, Germany, France) and Japan. As lead investor, they support promising start-ups and neglected late-stage projects to mitigate risks and create value. The team consists of specialists with extensive management and investment experience who coach bio-entrepreneurs through project development stages.

Asabys Partners is a Barcelona-based venture capital firm established in 2018 that focuses on investments in the life sciences and healthcare sectors. The firm targets innovative and transformative technologies within the health-tech and biopharma industries, both in Spain and internationally. Asabys Partners aims to advance the boundaries of science and medicine by financing disruptive technologies and collaborating with leading experts in the field.

Spreds is a Belgian investment platform established in 2011, facilitating co-investment between individuals and professionals in European startups and SMEs. It pioneered crowdfunding techniques for venture capital investments, enabling individuals to invest alongside professionals under the same terms, starting from €100. As of September 2012, Spreds has raised over €150 million and boasts a membership base exceeding 45,000 individuals.

Akiles is a Belgian investment company established since 2019, focusing on supporting the growth of small and medium-sized enterprises (SMEs) through management buy-in, buyout, venture capital, and growth capital investments. The firm primarily targets businesses operating in b2b, b2c, energy, financial services, materials & resources, and technology sectors across Europe.

Fund+ is a venture capital firm based in Leuven, Belgium, established in 2015. It invests in life sciences companies across seed, early, and later stages, with a focus on diagnostics, therapeutics, medical devices, and related sectors in Belgium. The firm seeks to build leadership in the life sciences field while delivering sustainable shareholder value and contributing to positive societal impact.

AngelWise is a venture capital firm founded in 2022 and headquartered in Hasselt, Belgium. The firm specializes in pre‑seed and seed‑stage investments, primarily in the information and communication technology sector. It provides comprehensive support to early‑stage startups, helping them advance to subsequent growth phases.

Fortino Capital is a Belgium-based venture capital and growth equity firm that provides expansion capital and strategic support to technology companies across Europe, with a focus on Western Europe and the Benelux region. It backs B2B SaaS and software firms, as well as media and high-end product manufacturing, helping SMEs build brands, sharpen go-to-market strategies, and scale internationally. The firm seeks companies that can reinvent their business models through best-in-class management practices and state-of-the-art technologies.

Established in 2016, KBC Focus Fund is a venture capital firm headquartered in Brussels, Belgium. It invests in growth-stage companies across Europe, with a focus on advanced technology sectors such as nanotechnology, microelectronics, and IoT.

Omnes Capital is a Paris‑based venture capital and private equity firm founded in 2000, with offices in Brussels and Zurich. The firm invests directly and through fund‑of‑funds in companies from seed to late stage across a broad range of sectors, including information technology, life sciences, agri‑food, telecommunications, renewable energy, infrastructure, and consumer services. It targets small and mid‑cap enterprises, typically with enterprise values between €8 million and €180 million, and deploys capital in the €1 million to €50 million range, depending on the stage. Omnes Capital prefers minority positions, seeks board representation, and usually holds investments for two to six years. The firm also participates in co‑investments for larger deals and has a global reach, focusing on Europe, North America, and parts of Latin America and Asia. Formerly known as Credit Agricole Private Equity, it has built a reputation for disciplined, long‑term value creation.

Inventures II is a venture capital fund based in Brussels, Belgium, managed by Inventures Investment Partners. Established in 2011, the fund focuses on early-stage investments in small and medium-sized enterprises across Europe, particularly in the pharmaceuticals and biotechnology sectors. It aims to support businesses that align with at least one of the United Nations Sustainable Development Goals, promoting sustainable development and societal progress. Additionally, Inventures II encourages citizen involvement in investment through its crowdfunding platform, MyMicroInvest, thereby enhancing community engagement and fostering entrepreneurship.

Established in 1988 and headquartered in Tournai, Belgium, WapInvest is a venture capital firm that focuses on direct investments across various stages of growth. It specializes in venture debt, incubation, startup, early, middle, late venture, growth capital, and emerging growth sectors.

Capital-E is an Antwerp-based venture capital firm that provides early-stage capital to startups developing electronics-enabled products and advanced materials, as well as technologies in industrial, consumer and related sectors across Western Europe. The firm maintains a close relationship with IMEC, Europe's leading independent research center in micro- and nano-electronics, enabling access to more than 2,000 scientists and engineers and to a global network of over 500 partners to support portfolio companies with technology validation, development and market adoption.

Fund+ NV is a venture capital firm specializes in start up and early stage investments. The firm typically invests in companies engaged in the life science sector with focus on therapeutics, diagnostics, and medical devices. It primarily invests in companies located in European developed markets. The firm seeks to invest between EUR3 million ($3.65 million) and EUR8 million ($9.75 million). The decision to enter or exit an investment will be reserved to the Management Committee or to the Board of Directors depending on the invested amount. It only invests in companies in advanced development stage and seeks to attain a significant minority stake between 10% and 20%. Fund+ NV is based in Leuven, Belguim.

Internet Attitude SA is a venture capital firm established in 2010 and headquartered in Lille, Belgium. The firm specializes in providing financial and strategic support to start-ups and growth-stage companies primarily in the internet and information technology sectors. It focuses on investments in areas such as web and mobile applications, software, deep tech, SaaS, data mining, and search algorithms. Internet Attitude typically invests between €0.3 million and €1 million, taking minority stakes in its portfolio companies while actively participating in their management. The firm primarily targets companies located in Belgium and France and does not engage in seed investments. Additionally, it considers co-investment opportunities, further enhancing its strategic involvement in the growth of its selected ventures.

Founded in Belgium, Droia Ventures is a specialized biotech investor focused exclusively on therapeutics for oncology and genetic diseases. They invest globally in early-stage companies applying novel science and innovative technologies to develop first-in-class drug candidates.

Lean FUND, established in 2014, is a Belgian venture capital firm specializing in seed and early-stage investments. It focuses on the internet industry, typically investing between €0.025 million and €0.1 million in startups with an enterprise value below €0.5 million. Based in Mont Saint Guibert, the firm excludes pharmaceuticals, biotech, healthcare, spinoffs, and hardware development from its investment scope. In addition to capital, Lean FUND offers coaching and support through its integrated Lean REACTOR program.

CAREvolution is a venture capital firm founded in 2016 and based in Bruxelles, Belgium. The firm focuses on investing in the healthcare sector, specifically targeting seed and early-stage opportunities. By concentrating on innovative healthcare solutions, CAREvolution aims to support the growth of companies that can advance medical technologies and improve patient care.

Founded in 1985, Sambrinvest is a Belgian venture capital firm based in Gosselies. It specializes in direct investments, focusing on small and medium-sized companies across various sectors such as Agri-Food, biotechnology, digital, manufacturing, and services. The firm primarily invests in the Charleroi Sud-Hainaut and Thuin districts of Belgium, with typical investment amounts not exceeding €1.25 million.

Finindus is an investment company that provides early-stage and growth financing to innovative companies focused on materials science, processing technologies, and sustainable manufacturing across the metal value chain. Typically investing €0.5 to €5 million per round, with a maximum of €10 million per company, Finindus actively contributes to portfolio companies' value creation through its network, expertise, and access to OCAS's research facilities.

Founded in 2005, Allegro is a venture capital firm based in Leuven, Belgium. It specializes in early-stage and spin-off investments, focusing on high-technology and disruptive technology sectors such as chips design, green energy, wireless technology, medical & diagnostic devices, and new materials.

ING Corporate Investments is the private equity arm of ING Group, headquartered in Brussels, Belgium. It invests in small and medium-sized enterprises in Belgium, Luxembourg and France, providing buy-out, development and venture capital. Active in private equity since 1997, it has supported companies across information technology, software, biotechnology, manufacturing, engineering, logistics, distribution, and telecommunications. The group has deployed over 100 million euros in investments.

Vectis is a Belgian-based investment firm, headquartered in Aalter, offering investment management, private equity, venture capital, management consulting, and business development services. Founded in 2004, the firm focuses on investing in Belgian companies, particularly in the business-to-business sector, and supports growth through capital and strategic guidance across stages and industries within Belgium.

Established in 2020, the European Innovation Council supports innovative startups and researchers with promising ideas, focusing on early-stage companies with positive environmental, social, or governance impacts. It co-invests alongside private investors.

AMAVI Capital is an independent European investor focused on supporting growth within the PropTech industry across Benelux, Nordics, Germany, Switzerland, and France. Established in 2020, AMAVI aims to bridge traditional real estate with innovative PropTech companies by leveraging its expertise from real estate, technology, and private equity sectors.

Beluga NV is a private equity and venture capital firm founded in 1998 and based in Ternat, Belgium. The firm specializes in acquiring and managing a diversified portfolio, focusing on mid and late venture, as well as growth capital investments in companies across various sectors, particularly in Belgium and the Flanders region. Beluga typically invests between €0.25 million and €2.5 million for minority stakes in both public and private companies, targeting enterprises with values ranging from €1 million to €250 million. The firm has a preference for sectors such as healthcare, B2B, B2C, energy, and financial services, and it seeks to support companies with sales values between €0.25 million and €500 million and EBITDA values from €1 million to €100 million.

Advantage Capital Partners is a United States‑based venture capital firm that provides growth equity, debt, and mezzanine financing to small and mid‑market companies, with a focus on underserved communities and state and local economic development. The firm invests across sectors including manufacturing, technology, business services, life sciences, and energy, and also supports real estate development projects with equity and debt. It typically makes initial investments ranging roughly from half a million to ten million in companies with modest sales, and may participate in larger follow‑on rounds or co‑invest with other firms. It uses senior debt, mezzanine debt, subordinated loans, and government‑guaranteed lending, and often pursues equity positions through preferred shares or convertible notes. Advantage Capital operates nationwide in the United States, with roots in New Orleans and offices in multiple states, and has backed thousands of jobs and housing projects as part of its mission to expand inclusive economic growth.

We Are Jane is a Belgium-based private equity and venture capital firm founded in 2019 and based in Roeselare that focuses on investing in companies founded or led by women. It targets opportunities in the business and consumer products and services, financial services, healthcare, and information technology sectors. The firm primarily invests in Belgian and regional companies, providing equity financing typically between 1.5 million and 7 million euros, in firms with at least 1.5 million euros in revenue.

S.R.I.W. Environnement S.A. is a private equity and venture capital firm specializing in middle market, later stage, mature, emerging growth, early venture, mid venture, late venture, industry consolidation, buyout, growth capital, venture debt, and mezzanine investments. The firm seeks to make investments in Wallonia through shareholdings in companies with a focus on companies that are involved in the development of industrial processes in the environment sector. The firm makes equity investments between €1 million ($1.62 million) and €50 million ($58.27 million) in companies having enterprise value minimum of €5 million ($5.82 million). The firm seeks to acquire a minority stake along with being present on the Board of Directors. The firm makes balance sheets investments. S.R.I.W. Environnement S.A. was founded in 1984 and is based in Liège, Belgium. It operates as a subsidiary of S.R.I.W. S.A.

Holland Capital, established in 1981 and based in Amsterdam, is a private equity and venture capital firm that specializes in direct investments and fund of fund investments. The firm focuses on early and later-stage investments in small and medium-sized enterprises, primarily within sectors such as healthcare, technology, consumer discretionary, and industrials. Holland Capital typically invests between €0.25 million and €10 million in companies with an enterprise value ranging from €5 million to €50 million. It aims to secure a minimum 20 percent equity stake in its portfolio companies and seeks exits through trade sales or initial public offerings. With a history of over 115 successful investments, Holland Capital operates two active funds: one targeting growing Dutch SMEs and another focused on innovative healthcare enterprises. The firm primarily invests in companies based in the Netherlands, Belgium, and Luxembourg.

Software Holding & Finance is a Belgian investment firm founded in 1996 and headquartered in Aarschot. The firm specialized in direct and fund‑of‑fund investments, focusing on mature, later‑stage, seed, early and mid‑venture companies, as well as private‑equity and venture‑capital funds. Its investment mandate targeted emerging technology sectors such as information technology, software, and telecommunications, with additional interest in biotechnology, pharmaceuticals, and new materials. The firm typically invested between €50,000 and €1 million through its own capital. The company ceased active investing in recent years.

Ninepointfive is a venture capital investment firm based in Antwerp, Belgium, founded in 2019. It co-invests with corporate partners to support tech startups from pre-seed to maturity, combining venture capital with corporate acceleration to drive growth. The firm works with brands such as Beiersdorf, Telenet, and Agfa to provide strategic value, resources, and market access for portfolio companies. Ninepointfive focuses on sectors including energy, information technology, B2B software as a service, and materials and resources, seeking startups with scalable technology and practical applications. By leveraging corporate networks and investment expertise, it helps founders move from early validation to scale in a pragmatic, value-driven approach.

Verlinvest is a private equity and venture capital firm focused on growth capital investments and strategic equity buyouts across consumer products, healthcare, education, and digital media. It pursues minority and majority stakes in mid to middle-market companies, including opportunities arising from succession planning in family businesses, sector shifts, and new growth opportunities. The firm typically makes equity investments ranging from €5 million to €100 million and seeks board representation on portfolio companies to support strategic direction and governance. With headquarters in Brussels and offices in New York, Paris and London, Verlinvest targets investments across Western and Central Europe, India, Southeast Asia, China, and the United States. Founded in 1995, it invests across sectors such as food and beverages, personal care and consumer services, education technology, e-commerce, and next-generation marketing and media tools, aiming to build long-term value through hands-on collaboration with management teams.

Bioqube Ventures NV is a venture capital firm based in Brussels, Belgium, established in 2016. The company specializes in early-stage investments in the life sciences sector, particularly targeting European biotech companies that are developing innovative therapeutic assets and technologies. Bioqube Ventures focuses on investments in the Benelux countries, France, and Germany, aiming to advance scientific innovation and support companies with medicines in the testing phase. The firm employs a dual investment model that includes traditional early investment rounds and special attention to projects that require additional de-risking before launching new ventures. With a diverse team of fund managers, sector experts, and serial entrepreneurs, Bioqube Ventures takes a hands-on approach to drive growth and maximize value for its portfolio companies and investors.

Isola Capital Group is a family office asset management platform based in Hong Kong, with an additional office in Belgium. Founded in 1946, the firm focuses on entrepreneurial and multi-asset class investments, including private equity, venture capital, and private credit. It specializes in mezzanine financing, pre-IPO investments, and various other financial instruments. Isola Capital Group operates through two main divisions: Isola Capital Partners, which targets direct investments in the Asia Pacific region, particularly in sectors such as education, healthcare, and premium consumer goods; and Isola Venture Partners, which invests globally in early-stage ventures across industries like EdTech, FinTech, and HealthTech. The firm aims to acquire either controlling or significant minority stakes in its investments, and also offers family office services including discretionary portfolio management and investment advisory. Isola is regulated by the Hong Kong Securities and Futures Commission.

TechVision Fund is a venture capital firm based in Aachen, Germany. It makes early-stage investments in software-as-a-service, software, Internet of Things, digital solutions, medtech, biotech, new materials, greentech, and cleantech across the Rhineland region and nearby parts of the Netherlands and Belgium. The firm provides strategic guidance and hands-on support to portfolio companies, assisting with product development, regulatory affairs, hiring, and sales. It emphasizes close, human-to-human engagement and leverages a regional network to back later funding rounds.

Torus Capital is a Belgian-based venture capital firm focusing on early-stage investments in software and hardware technology sectors. They actively engage with founders, sharing challenges and successes, driven by values beyond financial returns.